Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's Disease
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This study evaluates the safety and pharmacological effects of 3 different doses of Posiphen®
when compared to a placebo, in adult male and female patients with early Alzheimer's disease
(AD).